# Moses Vaporization: Is Use of Moses 2.0 in Holmium Laser Ablation of the Prostate More Efficient

> **NCT04979143** · NA · TERMINATED · sponsor: **University of Kansas Medical Center** · enrollment: 19 (actual)

## Conditions studied

- Benign Prostatic Hyperplasia
- Lower Urinary Tract Symptoms

## Interventions

- **PROCEDURE:** Surgical Approach

## Key facts

- **NCT ID:** NCT04979143
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-11-28
- **Primary completion:** 2025-05-12
- **Final completion:** 2025-07-07
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Slow recruitment due to new alternative surgical treatment options emerging and being requested by patients.
- **Last updated:** 2025-08-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04979143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04979143, "Moses Vaporization: Is Use of Moses 2.0 in Holmium Laser Ablation of the Prostate More Efficient". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04979143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*